Sign in Register

Drug class

Agents to Treat Restless Legs Syndrome (RLS)

"Agents to Treat Restless Legs Syndrome (RLS)" is a functional, indication-based classification rather than a single pharmacologic drug class, encompassing several distinct therapeutic categories. Read more about Agents to Treat Restless Legs Syndrome (RLS)

29 drugs in this class 25 manufacturers

Related classes & indications

Antipsychotics, AtypicalCNS, pain & psychiatry · 296 prescription drugs Antidepressant Serotonin-Norepinephrine Reuptake Inh.(SNRIs)CNS, pain & psychiatry · 127 prescription drugs

Showing 10–18 of 29 drugs

Sort

PRAMIPEXOLE DIHYDROCHLORIDE (pramipexole di-HCl)

ANTIPARKINSONIAN DOPAMINE AGONISTS · IDIOPATHIC PARKINSONISM ·+1

GSMS, INC.

PRAMIPEXOLE DIHYDROCHLORIDE (pramipexole di-HCl)

ANTIPARKINSONIAN DOPAMINE AGONISTS · IDIOPATHIC PARKINSONISM ·+1

AHP

ROPINIROLE HCL

ANTIPARKINSONIAN DOPAMINE AGONISTS · IDIOPATHIC PARKINSONISM ·+1

ALEMBIC PHARMAC

PRAMIPEXOLE DIHYDROCHLORIDE (pramipexole di-HCl)

ANTIPARKINSONIAN DOPAMINE AGONISTS · IDIOPATHIC PARKINSONISM ·+1

RISING PHARM

ROPINIROLE HCL

ANTIPARKINSONIAN DOPAMINE AGONISTS · IDIOPATHIC PARKINSONISM ·+1

GSK Consumer Healthcare

HORIZANT (gabapentin enacarbil)

ANTICONVULSANTS · POSTHERPETIC NEURALGIA ·+1

ARBOR/AZURITY

PRAMIPEXOLE DIHYDROCHLORIDE (pramipexole di-HCl)

ANTIPARKINSONIAN DOPAMINE AGONISTS · IDIOPATHIC PARKINSONISM ·+1

Major Pharamceuticals

PRAMIPEXOLE DIHYDROCHLORIDE (pramipexole di-HCl)

ANTIPARKINSONIAN DOPAMINE AGONISTS · IDIOPATHIC PARKINSONISM ·+1

SCIEGEN PHARMAC

ROPINIROLE HCL

ANTIPARKINSONIAN DOPAMINE AGONISTS · IDIOPATHIC PARKINSONISM ·+1

AVPAK

Filter & compare in the drug finder → Opens the drug finder with Agents to Treat Restless Legs Syndrome (RLS) preselected. Add indication or manufacturer filters there.

About Agents to Treat Restless Legs Syndrome (RLS).

"Agents to Treat Restless Legs Syndrome (RLS)" is a functional, indication-based classification rather than a single pharmacologic drug class, encompassing several distinct therapeutic categories.

The primary pharmacological classes utilized include alpha-2-delta calcium channel ligands—such as gabapentin, gabapentin enacarbil, and pregabalin—which modulate excitatory neurotransmitter release, as well as non-ergot dopamine receptor agonists like pramipexole and ropinirole, and supplemental iron formulations to address central iron dysregulation.

Clinically, these agents are primarily indicated to reduce the distressing urge to move the limbs, alleviate associated paresthesias, and mitigate sleep disruptions characteristic of moderate-to-severe restless legs syndrome, while select members are also indicated for neuropathic pain or Parkinson disease.

nih.gov
"Agents to Treat Restless Legs Syndrome (RLS)" is a functional, indication-based classification rather than a single pharmacologic drug class, encompassing several distinct therapeutic categories The primary pharmacological classes utilized include alpha-2-delta calcium channel ligands—such as gabapentin, gabapentin enacarbil, and pregabalin—which modulate excitatory neurotransmitter release, as well as non-ergot dopamine receptor agonists like pramipexole and ropinirole, and supplemental iron f...
nih.gov
"Agents to Treat Restless Legs Syndrome (RLS)" is a functional, indication-based classification rather than a single pharmacologic drug class, encompassing several distinct therapeutic categories The primary pharmacological classes utilized include alpha-2-delta calcium channel ligands—such as gabapentin, gabapentin enacarbil, and pregabalin—which modulate excitatory neurotransmitter release, as well as non-ergot dopamine receptor agonists like pramipexole and ropinirole, and supplemental iron f...
medlineplus.gov
The primary pharmacological classes utilized include alpha-2-delta calcium channel ligands—such as gabapentin, gabapentin enacarbil, and pregabalin—which modulate excitatory neurotransmitter release, as well as non-ergot dopamine receptor agonists like pramipexole and ropinirole, and supplemental iron formulations to address central iron dysregulation Clinically, these agents are primarily indicated to reduce the distressing urge to move the limbs, alleviate associated paresthesias, and mitigate...
medlineplus.gov
The primary pharmacological classes utilized include alpha-2-delta calcium channel ligands—such as gabapentin, gabapentin enacarbil, and pregabalin—which modulate excitatory neurotransmitter release, as well as non-ergot dopamine receptor agonists like pramipexole and ropinirole, and supplemental iron formulations to address central iron dysregulation
fda.gov
Clinically, these agents are primarily indicated to reduce the distressing urge to move the limbs, alleviate associated paresthesias, and mitigate sleep disruptions characteristic of moderate-to-severe restless legs syndrome, while select members are also indicated for neuropathic pain or Parkinson disease
medlineplus.gov
Clinically, these agents are primarily indicated to reduce the distressing urge to move the limbs, alleviate associated paresthesias, and mitigate sleep disruptions characteristic of moderate-to-severe restless legs syndrome, while select members are also indicated for neuropathic pain or Parkinson disease
medlineplus.gov
Clinically, these agents are primarily indicated to reduce the distressing urge to move the limbs, alleviate associated paresthesias, and mitigate sleep disruptions characteristic of moderate-to-severe restless legs syndrome, while select members are also indicated for neuropathic pain or Parkinson disease